SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals
Preprint
Abstract
The immune response to viral infection is shaped by past exposures to related virus strains, a phenomenon known as imprinting. For SARS-CoV-2, much of the population has been imprinted by a viral spike from an early strain, either through vaccination or infection during the early stages of the COVID-19 pandemic. As a consequence of this imprinting, infection with more recent SARS-CoV-2 strains primarily boosts cross-reactive antibodies elicited by the imprinting strain. Here we compare the neutralizing antibody specificities of imprinted individuals versus infants infected with a recent strain. Specifically, we use pseudovirus-based deep mutational scanning to measure how spike mutations affect neutralization by the serum antibodies of adults and children imprinted by the original vaccine versus infants with a primary infection by a XBB* variant. While the serum neutralizing activity of the imprinted individuals primarily targets the spike receptor-binding domain (RBD), serum neutralizing activity of infants only infected with XBB* mostly targets the spike N-terminal domain (NTD). In these infants, secondary exposure to the XBB* spike via vaccination shifts more of the neutralizing activity towards the RBD, although the specific RBD sites targeted are different than for imprinted adults. The dramatic differences in neutralization specificities among individuals with different exposure histories likely impact SARS-CoV-2 evolution.Keywords
All Related Versions
- Published version: Journal of Virology, 99 (4), e0010925.
This publication has 63 references indexed in Scilit:
- Evolution of the SARS-CoV-2 Omicron spikeCell Reports, 2023
- A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeCell, 2023
- Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spikeCell Reports, 2022
- Potent cross-reactive antibodies following Omicron breakthrough in vaccineesCell, 2022
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Cell, 2021
- The antigenic anatomy of SARS-CoV-2 receptor binding domainCell, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Variation in Response among Individuals to Antigenic Sites on the HA Protein of Human Influenza Virus May Be Responsible for the Emergence of Drift Strains in the Human PopulationVirology, 2000